Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2

UNC Libraries(2024)10.17615/swdf-sx88Source: DataRank Database

Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (29)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Baric R.S,Diamond M.S,Karl C.E,G Alter,Whitener B.M.

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4400026368

National Institutes of Health

Grant: 5R01AI157155-02

Human antibody-based countermeasures against the Coronavirus SARS-CoV-2

National Institutes of Health

Grant: 1R01AI110700-01A1

Mechanisms of MERS-CoV Entry, Cross-species Transmission and Pathogenesis

National Institutes of Health

Grant: 5T32AI007172-37

Infectious Disease/Basic Microbial Pathogenic Mechanisms

FWCI

0.00

Citation Percentile

0.1%

greenLicense: Springer Nature TDM

repositoryhttps://doi.org/10.17615/swdf-sx88

https://doi.org/10.1038/s41564-023-01359-1

https://dx.doi.org/10.17615/swdf-sx88

https://pubmed.ncbi.nlm.nih.gov/37012355

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchImmunodeficiency and Autoimmune Disorders0301 basic medicine03 medical and health sciences

Keywords

EffectorVirologyAntigenAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyCoronavirus disease 2019 (COVID-19)Immunology2019-20 coronavirus outbreakMedicineDiseaseInfectious disease (medical specialty)OutbreakMice, KnockoutVaccinesSARS-CoV-2Receptors, IgGCOVID-19Antibodies, ViralMiceAnimalsHumansBNT162 Vaccine2019-nCoV Vaccine mRNA-1273

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger